• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_SMART TOUCH BIDIRECTIONAL; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_SMART TOUCH BIDIRECTIONAL; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_SMART TOUCH BIDIRECTIONAL
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226)
Event Date 07/28/2023
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: hartl s, makimoto h, gerguri s, clasen l, kluge s, brinkmeyer c, schmidt j, rana o, kelm m, bejinariu a.Wide antral circumferential re-ablation for recurrent atrial fibrillation after prior pulmonary vein isolation guided by high-density mapping increases freedom from atrial arrhythmias.J clin med.2023 jul 28;12(15):4982.Doi: 10.3390/jcm12154982.Pmid: 37568384; pmcid: pmc10419947.Objective/methods/study data: the aim of this single-center study was to evaluate the benefit of waca pv re-ablation (re-waca) guided by three-dimensional (3d) high-density left atrial mapping (hdm) as compared to simple ostial re-pvi guided by a circular mapping catheter in patients who experienced af recurrences due to true pv reconnection or an exclusive documentation of residual antral pv potentials within the initial ablation line (without intra-pv potentials) after previous pvi.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool smarttouch (both groups).Other biosense webster devices that were also used in this study: carto mapping system(both groups), pentaray mapping catheter(in the re-waca group), lasso mapping catheter (in the historical re-pvi control group).Non-biosense webster devices that were also used in this study: n/a.Adverse event(s) and provided interventions possibly associated with unidentified smarttouch ablation catheter: qty 1 pericardial tamponade (cardiac tamponade) requiring drainage (recognized procedural complication) - occurred on (b)(6) 2018.Qty 1 small intracranial bleeding managed conservatively (minor injury) - authors provide via email response: the interventions were monitoring of vitals, adjustment of the antihypertensives and anticoagulants.Occurred on (b)(6) 2016.Authors provide information this case was high weight for low height (86kg, 147cm).Authors report there are no other adverse events that are associated with use of biosense webster devices within the study group.
 
Manufacturer Narrative
This complaint is from a literature source.The following literature cite has been reviewed: hartl s, makimoto h, gerguri s, clasen l, kluge s, brinkmeyer c, schmidt j, rana o, kelm m, bejinariu a.Wide antral circumferential re-ablation for recurrent atrial fibrillation after prior pulmonary vein isolation guided by high-density mapping increases freedom from atrial arrhythmias.J clin med.2023 jul 28;12(15):4982.Doi: 10.3390/jcm12154982.Pmid: 37568384; pmcid: pmc10419947.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc, or its employees that the report constitutes an admission that the product, biosense webster inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_SMART TOUCH BIDIRECTIONAL
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17950995
MDR Text Key325898686
Report Number2029046-2023-02339
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P030031/S053
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_SMART TOUCH BIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO MAPPING SYSTEM; LASSO MAPPING CATHETER; PENTARAY MAPPING CATHETER
Patient Outcome(s) Required Intervention; Life Threatening;
-
-